Moderna Therapeutics raised $40,000,000 on , from Flagship Ventures.

Get alertedif Moderna Therapeutics gets funded!
United States
Key people:Noubar Afeyan (Co-founder & Chairman, Founder & Chairman)
Stephane Bancel (President &Founding Chief Executive Officer)
Joe Bolen (President of Research and Development)
Robert Carpenter (Board of Directors)
Peter Haeberli (Senior Vice President of Intellectual Property and Legal Affairs)
Stephen Hoge (Senior Vice President of Corporate Development and New Drug Concepts)
Divakar Ramakrishnan (Senior Vice President of Process Development, Manufacturing and Quality)
John Reynders (Chief Information Officer)
Paula Soteropoulos (Cardiometabolism Business Unit General Manager and Senior Vice President of Strategic Alliances)
Henri Termeer (Board of Directors)
Data sources: - Moderna Therapeutics closes $40M in financing - Moderna Therapeutics closes $40M in financing | Tibidy Health - MEDAXS Medical Network- Connecting Healthcare Providers and Patients with Chronic Conditions - Moderna Therapeutics Closes over $40M in Financing | FinSMEs - Genomics Biotech Raises $40 Million in Venture Funds | Science Business
In 2012, December 6th, Moderna Therapeutics, a Cambridge, United States-based firm specializing in Biotechnology, closed a 40M investment.
Please note that all data is automatically extracted and errors can occur.
The WhoGotFunded team has not necessarily reviewed the information in this page and has not determined if it is accurate and complete.
Inaccurate Data? Help us improve WhoGotFunded: post a comment!